2 000 new building blocks are synthesized monthly. Here is an important update to our MedChem Highlights from February 2025
Recent News
-
02 April 2025 Press Release
Enamine and ChemPass Collaborate to Accelerate Hit Discovery
Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of strategic partnership to provide hit discovery solutions to their customers.
-
06 March 2025 News
Enamine REAL Compounds: A Practical Overview
Event Timing: Thursday, 24 April, 2025. Event Address: Suwon Convention Center, room 301+302. -
26 February 2025 Press Release
Enamine, Chemspace, and PharmAI Discovery Join Forces to Advance AI-Driven Drug Discovery for Novel Theranostics
Enamine, Chemspace, and PharmAI Discovery GmbH (PAID) start a transformative collaboration to accelerate the advancement of theranostics through AI-driven drug discovery with emphasis on cancer diagnosis and therapy. This collaboration brings together the success of Enamine’s discovery biology and chemistry competencies, Chemspace’s expertise in ultra-large chemical space exploration for drug discovery, and PAID’s AI-powered molecular discovery platform to identify and develop promising drug candidates faster and with greater precision, both for conventional and molecular radiotherapy and radio diagnostics.
Upcoming events
FOLLOW US
Request product information
Please leave your request for any product you wish. We will be happy to search it for you in our databases or offer its custom synthesis